Published in Psychopharmacology (Berl) on January 01, 1999
Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study. Behav Brain Funct (2007) 1.83
A point mutation to Galphai selectively blocks GoLoco motif binding: direct evidence for Galpha.GoLoco complexes in mitotic spindle dynamics. J Biol Chem (2008) 1.29
Infant genotype may moderate sensitivity to maternal affective communications: attachment disorganization, quality of care, and the DRD4 polymorphism. Soc Neurosci (2007) 1.15
Season of birth and dopamine receptor gene associations with impulsivity, sensation seeking and reproductive behaviors. PLoS One (2007) 1.09
WAY-100635 is a potent dopamine D4 receptor agonist. Psychopharmacology (Berl) (2006) 1.07
Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: an exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya. BMC Evol Biol (2008) 0.97
Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI. Psychopharmacology (Berl) (2008) 0.93
Polymorphisms in genes modulating the dopamine system: do they inf luence outcome and response to medication after traumatic brain injury? J Head Trauma Rehabil (2009) 0.85
Assortative human pair-bonding for partner ancestry and allelic variation of the dopamine receptor D4 (DRD4) gene. Soc Cogn Affect Neurosci (2009) 0.85
D2-like dopamine and β-adrenergic receptors form a signaling complex that integrates Gs- and Gi-mediated regulation of adenylyl cyclase. Cell Signal (2012) 0.82
Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonists. Bioorg Med Chem (2010) 0.81
Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08
Cloning and expression of a rat D2 dopamine receptor cDNA. Nature (1989) 3.59
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem (1995) 3.08
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature (1991) 2.41
Dopamine D4 receptors elevated in schizophrenia. Nature (1993) 2.09
A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet (1993) 2.09
Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride. J Neurochem (1995) 2.03
Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J Pharmacol Exp Ther (1999) 1.95
Dopamine receptor pharmacology. Trends Pharmacol Sci (1994) 1.85
The dopamine D(4) receptor: one decade of research. Eur J Pharmacol (2000) 1.69
Cloning and expression of human and rat D1 dopamine receptors. Nature (1990) 1.65
T cell receptor-beta mRNA splicing: regulation of unusual splicing intermediates. Mol Cell Biol (1993) 1.63
Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J Biol Chem (1990) 1.63
Dopamine receptor genes: new tools for molecular psychiatry. J Psychiatry Neurosci (1992) 1.53
[Maternal and neonatal plasma concentrations of bupivacaine during peridural anesthesia for cesarean section]. Reg Anaesth (1990) 1.39
Quantitation of vasopressin mRNA and oxytocin mRNA in hypothalamic nuclei by solution hybridization assays. J Neurochem (1986) 1.22
Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A (1989) 1.17
Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. Mol Pharmacol (1996) 1.16
Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics (1999) 1.16
Release of dopamine via the human transporter. Mol Pharmacol (1994) 1.16
A spliced intron accumulates as a lariat in the nucleus of T cells. Nucleic Acids Res (1992) 1.16
Molecular biology of the dopamine receptors. Eur J Pharmacol (1991) 1.14
Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol (1994) 1.14
Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors. J Neurochem (1992) 1.13
Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors. J Pharmacol Exp Ther (1986) 1.06
SH3 binding domains in the dopamine D4 receptor. Biochemistry (1998) 1.06
Molecular cloning and expression of the rat beta 1-adrenergic receptor gene. J Biol Chem (1990) 1.06
Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonist-specific active conformations. Mol Pharmacol (1998) 1.03
[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux. Synapse (1998) 1.02
Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy? J Exp Clin Cancer Res (2000) 1.01
T cell receptor-beta mRNA splicing during thymic maturation in vivo and in an inducible T cell clone in vitro. J Immunol (1993) 1.01
Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology (1997) 0.99
Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion. J Biol Chem (1990) 0.99
Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor. Mol Pharmacol (2001) 0.98
A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol (1986) 0.98
Oxytocin gene expression in discrete hypothalamic magnocellular cell groups is stimulated by prolonged salt loading. Endocrinology (1987) 0.97
Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology (1994) 0.97
Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. J Neurosci (1998) 0.96
Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. Br J Anaesth (2005) 0.94
Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors. Mol Pharmacol (1997) 0.94
Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade. Mol Pharmacol (1986) 0.93
Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy. Qual Life Res (2000) 0.93
D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells. J Neurochem (1998) 0.92
Genomic organization and promoter analysis of the human G-protein-coupled K+ channel Kir3.1 (KCNJ3/HGIRK1). Genomics (1997) 0.91
Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand. Eur J Pharmacol (1995) 0.91
Characterization of a recombinant human dopamine transporter in multiple cell lines. J Pharmacol Exp Ther (1995) 0.90
Computer-assisted video analysis of [3H]spiroperidol binding autoradiographs. J Neurosci Methods (1984) 0.90
Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg (1993) 0.89
Constitutive activity of a chimeric D2/D1 dopamine receptor. Mol Pharmacol (1997) 0.89
Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. J Neurochem (1997) 0.89
Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action. J Psychiatr Res (1997) 0.89
Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. J Pharmacol Exp Ther (1991) 0.88
Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists. J Pharmacol Exp Ther (1985) 0.88
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors. Psychopharmacology (Berl) (1995) 0.87
Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two, four, and twelve or fifteen months of age. J Pediatr (1994) 0.87
Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells. J Neurosci (1998) 0.87
Interaction of beta-adrenergic receptors with the inhibitory guanine nucleotide-binding protein of adenylate cyclase in membranes prepared from cyc- S49 lymphoma cells. Biochem Pharmacol (1988) 0.86
Drug-induced up-regulation of dopamine D2 receptors on cultured cells. J Neurochem (1995) 0.86
Cloning of a G protein-activated inwardly rectifying potassium channel from human cerebellum. Brain Res Mol Brain Res (1996) 0.86
Transcription of a human dopamine D5 pseudogene. Biochem Biophys Res Commun (1991) 0.86
Antisense GAP-43 inhibits the evoked release of dopamine from PC12 cells. J Neurochem (1993) 0.86
A human serotonin 1D receptor variant (5HT1D beta) encoded by an intronless gene on chromosome 6. Proc Natl Acad Sci U S A (1992) 0.86
Serotonin receptor cDNA cloned from Lymnaea stagnalis. Proc Natl Acad Sci U S A (1993) 0.85
Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction. J Biol Chem (1994) 0.85
Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury. Brain Res (1984) 0.84
Co-expression of human Kir3 subunits can yield channels with different functional properties. Cell Signal (1999) 0.84
Recovery of function after mesotelencephalic dopaminergic injury in senescence. Brain Res (1983) 0.84
Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma. Proc Natl Acad Sci U S A (1990) 0.83
Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity. Brain Res (1982) 0.83
The D4 dopamine receptor gene maps on 11p proximal to HRAS. Genomics (1993) 0.83
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors. J Med Chem (2000) 0.83
Prenatal diagnosis of epidermolysis bullosa dystrophica Hallopeau-Siemens with electron microscopy of fetal skin. Lancet (1981) 0.82
Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. Eur J Pharmacol (1998) 0.82
Dopamine receptors and antipsychotic drug response. Br J Psychiatry Suppl (1993) 0.82
Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism. Jpn J Pharmacol (1996) 0.82
Pure red cell aplasia evolving through the hyperfibrotic myelodysplastic syndrome to the acute myeloid leukemia: some pathogenetic aspects. Hematol Cell Ther (1999) 0.82
Role of dopamine D2, D4 and serotonin(2A) receptors in antipsychotic and anticataleptic action. J Psychopharmacol (1997) 0.81
Dopamine D4 receptor variant in Africans, D4valine194glycine, is insensitive to dopamine and clozapine: report of a homozygous individual. Am J Med Genet (1996) 0.81
Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine. J Pharmacol Exp Ther (1992) 0.81
Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Galphas: characterization of Galphas-insensitive mutants of adenylyl cyclase V. Mol Pharmacol (2001) 0.81
Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: no association with schizophrenia. Am J Med Genet (1994) 0.80
Regulation and functional characterization of a rat recombinant dopamine D3 receptor. Synapse (1995) 0.80
Diurnal variation in vasopressin and oxytocin messenger RNAs in hypothalamic nuclei of the rat. Brain Res (1988) 0.80
Regulation of melatonin 1a receptor signaling and trafficking by asparagine-124. Mol Endocrinol (2001) 0.80
Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors. Am J Cardiol (1986) 0.80
Nature of the oligomers formed by muscarinic m2 acetylcholine receptors in Sf9 cells. Eur J Pharmacol (2001) 0.80
The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography. Eur J Pharmacol (1992) 0.80
Functional compartmentalization following induction of long-term graft survival with pregraft donor-specific transfusion. Am J Transplant (2007) 0.80
A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides. FEBS Lett (1993) 0.80
Association study between the dopamine D4 receptor gene and schizophrenia. Am J Med Genet (1995) 0.79
Alleles at the dopamine D4 receptor locus do not contribute to the genetic susceptibility to schizophrenia in a large Swedish kindred. Am J Med Genet (1993) 0.79
Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline. Synapse (1997) 0.79
Chronic cognitive sequelae after traumatic brain injury are not related to growth hormone deficiency in adults. Eur J Neurol (2009) 0.78
Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors. J Med Chem (1996) 0.78